Select Micro-RNAs (miRs) Are Upregulated in Human Papillomavirus (HPV) 6 and 11-Induced Recurrent Respiratory Papillomatosis (RRP)

被引:0
|
作者
Diaz, J. M. [1 ]
Rosenthal, D. W. [1 ,2 ]
DeVoti, J. A. [2 ]
Bonagura, V. R. [1 ,2 ]
机构
[1] N Shore LIJ Hlth Syst, Schneider Childrens Hosp, Manhasset, NY USA
[2] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA
关键词
D O I
10.1016/j.jaci.2009.12.298
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB76 / AB76
页数:1
相关论文
共 41 条
  • [21] Genomic diversity of HPV6 and HPV11 in recurrent respiratory papillomatosis: Association with malignant transformation in the lungs and clinical outcomes
    Rahmoun, Massilva
    Aussel, Audrey
    Bouzidi, Sarah
    Pedergnana, Vincent
    Malassigne, Victor
    Puech, Julien
    Veyer, David
    Pere, Helene
    Lepine, Charles
    Blanc, Fabian
    Boulle, Nathalie
    Costes-Martineau, Valerie
    Bravo, Ignacio G.
    TUMOUR VIRUS RESEARCH, 2024, 18
  • [22] Reduced TH1 responses to HPV6/11 E6 protein in recurrent respiratory papillomatosis
    DeVoti, JA
    Bonagura, V
    Steinberg, B
    FASEB JOURNAL, 2001, 15 (05): : A1010 - A1010
  • [23] Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States
    Meites, Elissa
    Stone, Laura
    Amiling, Raiza
    Singh, Vidisha
    Unger, Elizabeth R.
    Derkay, Craig S.
    Markowitz, Lauri E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 885 - 890
  • [24] Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11
    Vambutas, A
    Bonagura, VR
    Reed, EF
    Abramson, AL
    Mullooly, V
    DeVoti, J
    Gjertson, DW
    Steinberg, BM
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05): : 871 - 879
  • [25] Long-Term Infection With a Particular Human Papillomavirus (HPV) Genotype, HPV Subtype, or HPV Genomic Variant Does not Significantly Influence the Clinical Course of Recurrent Respiratory Papillomatosis
    Gluvajic, Dasa
    Hosnjak, Lea
    Zorec, Tomaz Mark
    Gale, Nina
    Boltezar, Irena Hocevar
    Poljak, Mario
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)
  • [26] Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis
    Zhan, Chu-qin
    Yi, Song
    Liu, Xue-jun
    Nan, Ben-yu
    Huang, Sai-yu
    Chen, Bo-bei
    JOURNAL OF VOICE, 2019, 33 (03) : 363 - 369
  • [27] Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile-onset recurrent respiratory papillomatosis in China
    Xiao, Yang
    Wang, Jun
    Ma, Lijing
    Ren, Jiaming
    Yang, Molei
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (04) : 686 - 694
  • [28] Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53
    Rady, PL
    Schnadig, VJ
    Weiss, RL
    Hughes, TK
    Tyring, SK
    LARYNGOSCOPE, 1998, 108 (05): : 735 - 740
  • [29] Longitudinal measures of human papilloimavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis
    Maloney, Elizabeth M.
    Unger, Elizabeth R.
    Tucker, Ruth Ann
    Swan, David
    Karem, Kevin
    Todd, N. Wendell
    Reeves, William C.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (07) : 711 - 715
  • [30] Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis
    Aggarwal, Charu
    Cohen, Roger B.
    Morrow, Matthew P.
    Kraynyak, Kimberly A.
    Sylvester, Albert J.
    Cheung, Jocelyn
    Dickerson, Kelsie
    Schulten, Veronique
    Knoblock, Dawson
    Gillespie, Elisabeth
    Bauml, Joshua M.
    Yan, Jian
    Diehl, Malissa
    Boyer, Jean
    Dallas, Michael
    Kim, J. Joseph
    Weiner, David B.
    Skolnik, Jeffrey M.
    VACCINES, 2020, 8 (01)